B · Normal On September 8, Novartis suspended trading due to setbacks in the DEL-DESIRAN drug trial, and its latest decline was 8.8%. Global market intelligence 🕐 2026-09-08 15:11 #Global market intelligence 🖼️ Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇ Share 🔗Copy Link 📘Facebook 🐦X (Twitter) 💬WhatsApp 💼LinkedIn 👽Reddit ← Back to Telegraph
Comments